1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Cellectar, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors I-131-CLR1404 - Solid Tumors | Phase 1 | Completed | Cellectar, Inc | 9 | 2009-06-01 | 2010-05-04 |
Neoplasms (1) · Recurrence (1)
CLR1404 (1) · lortalamine (1)
United States (1)